Eloxx Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Eloxx Pharmaceuticals, Inc.‘s stocks are currently a part of 12 hedge funds’ portfolios, which represents 7.93% of the total amount of its stocks outstanding. This makes up a total of 171.83K shares of Eloxx Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -34.42% or -90.18K shares fewer. As for the holding position changes, 8.33% (1) of current hedge fund investors increased the number of shares held, 16.67% (2) of current holders sold a part of the shares held, and 8.33% (1) closed the holdings completely. 1 hedge funds are new holders of Eloxx Pharmaceuticals, Inc. stock in Q1 2023, it is 8.33% of total holders.
Hedge funds holding Eloxx Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 40 |
|---|---|
| Q3 2018 | 38 |
| Q4 2018 | 38 |
| Q1 2019 | 40 |
| Q2 2019 | 47 |
| Q3 2019 | 48 |
| Q4 2019 | 46 |
| Q1 2020 | 41 |
| Q2 2020 | 39 |
| Q3 2020 | 37 |
| Q4 2020 | 40 |
| Q1 2021 | 37 |
| Q2 2021 | 45 |
| Q3 2021 | 39 |
| Q4 2021 | 37 |
| Q1 2022 | 32 |
| Q2 2022 | 27 |
| Q3 2022 | 26 |
| Q4 2022 | 17 |
| Q1 2023 | 12 |
Hedge funds changes in Eloxx Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 40 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 17 | 7 | 7 | 2 |
| Q4 2018 | 4 | 15 | 12 | 4 | 3 |
| Q1 2019 | 3 | 13 | 12 | 1 | 11 |
| Q2 2019 | 9 | 20 | 10 | 0 | 8 |
| Q3 2019 | 6 | 23 | 11 | 5 | 3 |
| Q4 2019 | 5 | 21 | 11 | 7 | 2 |
| Q1 2020 | 4 | 13 | 18 | 8 | -2 |
| Q2 2020 | 3 | 21 | 7 | 5 | 3 |
| Q3 2020 | 1 | 7 | 17 | 3 | 9 |
| Q4 2020 | 4 | 15 | 9 | 1 | 11 |
| Q1 2021 | 1 | 9 | 13 | 4 | 10 |
| Q2 2021 | 22 | 10 | 9 | 14 | -10 |
| Q3 2021 | 8 | 12 | 11 | 14 | -6 |
| Q4 2021 | 9 | 8 | 14 | 11 | -5 |
| Q1 2022 | 3 | 7 | 12 | 8 | 2 |
| Q2 2022 | 3 | 4 | 10 | 8 | 2 |
| Q3 2022 | 3 | 4 | 8 | 3 | 8 |
| Q4 2022 | 16 | 1 | 0 | 25 | -25 |
| Q1 2023 | 1 | 1 | 2 | 1 | 7 |
Hedge funds changes in Eloxx Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 1,000 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 233,000 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 604,000 | 636,000 |
| Q3 2021 | 812,000 | 525,000 |
| Q4 2021 | 15,000 | 59,000 |
| Q1 2022 | 1,000 | 2,000 |
| Q2 2022 | 3,000 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |